First Time Loading...

Grifols SA
NASDAQ:GRFS

Watchlist Manager
Grifols SA Logo
Grifols SA
NASDAQ:GRFS
Watchlist
Price: 6.39 USD -5.89% Market Closed
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one GRFS stock under the Base Case scenario is 34.69 USD. Compared to the current market price of 6.39 USD, Grifols SA is Undervalued by 82%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GRFS Relative Value
Base Case
34.69 USD
Undervaluation 82%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.9
P/S
P/S
Price to Sales
0.9
vs History
92
vs Industry
88
Median 3Y
1.8
Median 5Y
2.5
Industry
8.1
Forward
0.8
More Details
100.1
P/E
P/E
Price to Earnings
100.1
vs History
9
vs Industry
1
Median 3Y
24.8
Median 5Y
23.8
Industry
26.2
Forward
16
More Details
28.5
P/OCF
P/OCF
Price to OCF
28.5
vs History
26
vs Industry
6
Median 3Y
19.2
Median 5Y
21.3
Industry
22.6
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
3.9
Median 5Y
7.7
Industry
21.3
More Details
1
P/B
P/B
Price to Book Value
1
vs History
92
vs Industry
61
Median 3Y
1.5
Median 5Y
2.7
Industry
2.5
More Details
2.2
EV/S
EV/S
Enterprise Value to Sales
2.2
vs History
80
vs Industry
69
Median 3Y
3.3
Median 5Y
3.6
Industry
7.3
Forward
2
More Details
5.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.8
vs History
80
vs Industry
54
Median 3Y
8.1
Median 5Y
8
Industry
9.1
More Details
12.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12.3
vs History
87
vs Industry
9
Median 3Y
15.7
Median 5Y
14.8
Industry
4.4
Forward
8
More Details
19.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
19.7
vs History
47
vs Industry
7
Median 3Y
20.9
Median 5Y
19.5
Industry
4.3
Forward
11.3
More Details
69.6
EV/OCF
EV/OCF
Enterprise Value to OCF
69.6
vs History
11
vs Industry
2
Median 3Y
26.7
Median 5Y
29.6
Industry
5.4
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-148.2
Median 5Y
33.2
Industry
3.2
More Details
0.7
EV/IC
EV/IC
Enterprise Value to IC
0.7
vs History
95
vs Industry
63
Median 3Y
0.9
Median 5Y
1.4
Industry
5
More Details

Multiples Across Competitors

GRFS Competitors Multiples
Grifols SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
ES
Grifols SA
NASDAQ:GRFS
5.9B USD 0.9 100.1 12.3 19.7
US
Abbvie Inc
NYSE:ABBV
281.3B USD 5.2 58.4 12.7 19.4
US
Amgen Inc
NASDAQ:AMGN
148.1B USD 5.3 22 16.4 24.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.8B USD 10.5 28.7 23 24
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
101.7B USD 7.8 25.7 17.2 18.9
AU
CSL Ltd
ASX:CSL
133B AUD 6.2 35.4 21.4 26.6
US
Gilead Sciences Inc
NASDAQ:GILD
81.1B USD 3 167.6 6.7 8.8
US
Moderna Inc
NASDAQ:MRNA
45.8B USD 6.7 -9.7 -10.4 -8.9
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
31.3B USD 3.2 26.8 13.8 17.2
KR
Celltrion Inc
KRX:068270
38.9T KRW 17.9 72.5 44.4 61.1

See Also

Summary
GRFS intrinsic value, competitors valuation, and company profile.
DCF Valuation
GRFS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GRFS stock valuation using valuation multiples.
Wall Street Estimates
GRFS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GRFS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.